Lataa...
COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
BACKGROUND: As of November 2020, severe acute respiratory syndrome coronavirus 2 has resulted in 55 million infections worldwide and more than 1.3 million deaths from coronavirus disease 2019 (COVID-19). Outcomes following severe acute respiratory syndrome coronavirus 2 infection in individuals with...
Tallennettuna:
| Julkaisussa: | J Allergy Clin Immunol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Academy of Allergy, Asthma & Immunology
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7737531/ https://ncbi.nlm.nih.gov/pubmed/33338534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2020.12.620 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|